N-(2-Chlorophenyl)-4-oxo-4-(2'-oxo-1',4'-dihydro-2'H-spiro[pyrrolidine-2,3'-quinolin]-1-yl)but-2-enamide

Catalog No. :
ACOIQH197
CAS No. :
2763387-69-3
Molecular Formula :
C22H20ClN3O3
Molecular Weight :
409.87

IUPAC Name:N-(2-chlorophenyl)-4-oxo-4-(2'-oxo-1',4'-dihydro-2'H-spiro[pyrrolidine-2,3'-quinolin]-1-yl)but-2-enamide

N-(2-Chlorophenyl)-4-oxo-4-(2'-oxo-1',4'-dihydro-2'H-spiro[pyrrolidine-2,3'-quinolin]-1-yl)but-2-enamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Chlorophenyl)-4-oxo-4-(2'-oxo-1',4'-dihydro-2'H-spiro[pyrrolidine-2,3'-quinolin]-1-yl)but-2-enamide
IUPAC NameN-(2-chlorophenyl)-4-oxo-4-(2'-oxo-1',4'-dihydro-2'H-spiro[pyrrolidine-2,3'-quinolin]-1-yl)but-2-enamide
Molecular FormulaC22H20ClN3O3
Molecular Weight409.87
SMILESO=C(C=CC(=O)N1CCCC12CC1=C(C=CC=C1)NC2=O)NC1=CC=CC=C1Cl
InChI KeyWYUGBSZAHFZXDM-UHFFFAOYSA-N
Synonym2-Butenamide, N-(2-chlorophenyl)-4-(1',4'-dihydro-2'-oxospiro[pyrrolidine-2,3'(2'H)-quinolin]-1-yl)-4-oxo-
CAS No.2763387-69-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACOIQH197 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOIQH197 route product structure diagram
    ACOIQH1972763387-69-3
Inquiry

2. ACOIQH197 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOIQH197 route product structure diagram
    ACOIQH1972763387-69-3
Inquiry

Comments (0)